Galera Announces First Patient Dosed with GC4711 in Phase 2b GRECO-2 Trial in Patients with Pancreatic Cancer

NEXT STORY
Paratek Pharmaceuticals Announces First Quarter 2021 Total Revenue of $16.4 Million and Initiation of First BARDA Procurement
PREV STORY
Global Test and Measurement Equipment Market to Grow at a CAGR of 4.0% from 2021 to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oncobiologics Secures Additional Funding

CRANBURY, N.J., April 17, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

SELLAS Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Latin American Disinfectant Sprays & Wipes Market 2019-2028 – Rising Complications from Healthcare-Associated Infections and COVID-19

author_avatar
NASDAQ Market News